Cargando…
Isoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasis
Breast cancer is one of the most frightful causes of death among females worldwide. Accumulating evidence attached the importance of microRNAs negative regulation to tumorigenesis in breast cancer, suggesting novel cancer therapies targeting microRNAs modulation. Recent studies demonstrated that iso...
Autores principales: | Peng, Fu, Tang, Hailin, Liu, Peng, Shen, Jiangang, Guan, Xinyuan, Xie, Xiaofang, Gao, Jihai, Xiong, Liang, Jia, Lei, Chen, Jianping, Peng, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567123/ https://www.ncbi.nlm.nih.gov/pubmed/28827662 http://dx.doi.org/10.1038/s41598-017-08422-y |
Ejemplares similares
-
Author Correction: Isoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasis
por: Peng, Fu, et al.
Publicado: (2023) -
Isoliquiritigenin Derivative Regulates miR-374a/BAX Axis to Suppress Triple-Negative Breast Cancer Tumorigenesis and Development
por: Peng, Fu, et al.
Publicado: (2020) -
Dietary compound isoliquiritigenin prevents mammary carcinogenesis by inhibiting breast cancer stem cells through WIF1 demethylation
por: Wang, Neng, et al.
Publicado: (2015) -
Isoliquiritigenin inhibits circ0030018 to suppress glioma tumorigenesis via the miR‐1236/HER2 signaling pathway
por: Liu, Aiqun, et al.
Publicado: (2023) -
Maackiain Modulates miR-374a/GADD45A Axis to Inhibit Triple-Negative Breast Cancer Initiation and Progression
por: Peng, Fu, et al.
Publicado: (2022)